Search
Now showing items 1-1 of 1
Unpacking the effects of adverse regulatory events: Evidence from pharmaceutical relabeling
(Research Policy, 2020-09-12)
We provide causal evidence that regulation induced product shocks significantly impact aggregate demand and firm performance in pharmaceutical markets. Event study results suggest an average loss between $569 million and ...